Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome

Molecular and Cellular Endocrinology

Volumn 350, Issue 1, 2012, Pages 72-77

  Hill, Lori D ^a   Ewens, Kathryn G ^b   Maher, Brion S ^a   York, Timothy P ^a   Legro, Richard S ^c   Dunaif, Andrea ^d   Strauss, Jerome F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Catechol O methyltransferase; COMT; Polycystic ovary syndrome; Prolactin

Indexed keywords

PROLACTIN; TESTOSTERONE;

ADOLESCENT; ADULT; ALLELE; ANOVULATION; ARTICLE; CATECHOL O METHYLTRANSFERASE GENE; CONTROLLED STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MOLECULAR PHYLOGENY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLACTIN; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TESTOSTERONE; YOUNG ADULT;

EID: 84856055587     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.11.022     Document Type: Article

References (32)

1. Abecasis G.R., Cardon L.R., Cookson W.O. A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 2000, 66:279-292.
2. Alexander N., Osinsky R., Mueller E., Schmitz A., Guenthert S., Kuepper Y., Hennig J. Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity, recovery. Behav. Brain Res. 2011, 216:53-58.
3. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 2004, 89:2745-2749.
4. Basini G., Bussolati S., Santini S.E., Bianchi F., Careri M., Mangia A., Musci M., Grasselli F. Antiangiogenesis in swine ovarian follicle: a potential role for 2-methoxyestradiol. Steroids 2007, 72:660-665.
5. Basini G., Santini S.E., Grasselli F. 2-Methoxyestradiol inhibits superoxide anion generation while it enhances superoxide dismutase activity in swine granulosa cells. Ann. NY Acad. Sci. 2006, 1091:34-40.
6. Dunaif A., Scott D., Finegood D., Quintana B., Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1996, 81:3299-3306.
7. Eichenlaub-Ritter U., Winterscheidt U., Vogt E., Shen Y., Tinneberg H.R., Sorensen R. 2-methoxyestradiol induces spindle aberrations, chromosome congression failure, and nondisjunction in mouse oocytes. Biol. Reprod. 2007, 76:784-793.
8. Filho R.B., Domingues L., Naves L., Ferraz E., Alves A., Casulari L.A. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol. Endocrinol. 2007, 23(5):267-272.
9. Hill L.D., York T.P., Kusanovic J.P., Gomez R., Eaves L.J., Romero R., Strauss J.F. Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One 2011, 6:e16681.
10. Jabbi M., Kema I.P., van der Pompe G., te Meerman G.J., Ormel J., den Boer J.A. Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatr. Genet. 2007, 217:183-193.
11. Keranen T., Gordin A., Koulu M., Scheinin M., Antila S., Sundberg S., Wikberg T. COMT inhibition by entacapone does not affect growth hormone or prolactin secretion in healthy volunteers. J. Neural Transm. 1996, 103:729-736.
12. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 1998, 83:3078-3082.
13. Lamberts S.W., Oosterom R. Absence of a suppressive effect of 2-hydroxyestrone on hyperprolactinemia in patients with prolactinomas before and after estradiol administration. J. Clin. Endocrinol. Metab. 1983, 56:230-233.
14. Legro R.S., Driscol I.D., Strauss J.F., Fox J., Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA 1998, 95:14956-14960.
15. Mannisto P.T., Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 1999, 51:593-628.
16. Merriam G.R., Pfeiffer D.G., Loriaux D.L., Lipsett M.B. Catechol estrogens and the control of gonadotropin and prolactin secretion in man. J. Steroid Biochem. 1983, 19:619-625.
17. Murdoch A.P., Dunlop W., Kendall-Taylor P. Studies of prolactin secretion in polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 1986, 24:165-175.
18. Nackley A.G., Shabalina S.A., Tchivileva I.E., Satterfield K., Korchynskyi O., Makarov S.S., Maixner W., Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006, 314:1930-1933.
19. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
20. Purcell S., Neal B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
21. Salih S.M., Jamaluddin M., Salama S.A., Fadl A.A., Nagamani M., Al-Hendy A. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertil. Steril. 2008, 89:1414-1421.
22. Salih S., Xu X., Veenstra T.D., Duleba A.J., Fouad H., Nagamani M., Al-Hendy A. Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007, 92:3285-3291.
23. Shang W., Konidari I., Schomberg D.W. 2-Methoxyestradiol, an endogenous estradiol metabolite differentially inhibits granulosa and endothelial cell mitosis: a potential follicular antiangiogenic regulator. Biol. Reprod. 2001, 65:622-627.
24. Schmidt J., Brännström M., Landin-Wilhelmsen K., Dahlgren E. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50years ago and their age-matched controls. J. Clin. Endocrinol. Metab. 2011, 96:2178-2185.
25. Spicer L.J., Hammond J.M. Catecholestrogens inhibit proliferation and DNA synthesis of porcine granulosa cells in vitro: comparison with estradiol, 5 alpha-dihydrotestosterone gonadotropins and catecholamines. Mol. Cell. Endocrinol. 1989, 64:119-126.
26. Spicer L.J., Hammond J.M. Comparative effects of androgens and catecholestrogens on progesterone production by porcine granulosa cells. Mol. Cell. Endocrinol. 1988, 56:211-217.
27. 3H]2-hydroxyestradiol by cultured porcine granulosa cells: evidence for the presence of a catechol-O-methyltransferase pathway and a direct stimulatory effect of 2-methoxyestradiol on progesterone production. Biol. Reprod. 1987, 36:562-571.
28. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 1993, 52:506-516.
29. Torre D.L., Falorni A. Pharmacological causes of hyperprolactinemia. Ther. Clin. Risk Manag. 2007, 3:929-951.
30. Urbanek M., Legro R.S., Driscoll D.A., Azziz R., Ehrmann D.A., Norman R.J., Strauss J.F., Spielman R.S., Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl. Acad. Sci. USA 1999, 96:8573-8585.
31. Walder D.J., Trotman H.D., Cubells J.F., Brasfield J., Tang Y.L., Walker E.F. Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents. Psychiatr. Genet. 2010, 20:166-170.
32. Yasui-Furukori N., Saito M., Tsuchimine S., Nakagami T., Sato Y., Sugawara N., Kaneko S. Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1491-1495.